HPV Vaccine (Gardasil®9)

Protects against the human papillomavirus, which is linked to several cancers later in life.

School-based program Publicly funded
Protects Against
Infection with nine HPV types (6, 11, 16, 18, 31, 33, 45, 52, 58), which are linked to cervical, anal, throat, and other cancers, as well as genital warts.
Ontario Routine Timing
Offered free in Grade 7 through school-based clinics. Catch-up is publicly funded through Grade 12.
Number of Doses
2 doses, at least 6 months apart, when started at age 9–14. A third dose is publicly funded for those who need it.
Publicly Funded Status
Yes — free for all students in Grade 7 (and as catch-up through Grade 12).
Bottom line: The HPV vaccine is a cancer-prevention vaccine offered free to all Grade 7 students in Ontario through school clinics. It is publicly funded and recommended, but it is not required for school attendance under Ontario law — this makes it different from vaccines like MMR or Tdap-IPV. It works best when given before any exposure to HPV, which is why it's offered in early adolescence.

What it protects against

HPV (human papillomavirus) is a very common virus. Most people will be exposed to it at some point, and in many cases the body clears it on its own. But some types can lead to cancer or other diseases years later. The vaccine protects against nine of the highest-risk and most common types.

What HPV can cause What it involves How it spreads Why it can be serious How vaccination helps
Cervical cancer Cancer of the cervix, often developing years or decades after HPV infection. HPV spreads through intimate skin-to-skin contact. Certain HPV types cause the large majority of cervical cancers. The vaccine protects against the HPV types responsible for most cervical cancers, ideally before any exposure.
Other cancers HPV is also linked to cancers of the anus, penis, vulva, vagina, and throat/mouth (oropharyngeal). Intimate skin-to-skin contact. These cancers can affect people of any gender, which is why the vaccine is offered to all children, not only girls. By preventing infection with high-risk HPV types, the vaccine reduces the risk of these cancers later in life.
Genital warts Warts in the genital area, caused by certain lower-risk HPV types. Intimate skin-to-skin contact. Not cancerous, but can cause distress and require treatment. Gardasil 9 includes protection against the two HPV types that cause most genital warts.
Why it matters that this is a cancer-prevention vaccine: Unlike most childhood vaccines, which prevent infections that cause illness soon after exposure, the HPV vaccine prevents infections that can lead to cancer many years later. This long time gap is part of why it's given in early adolescence — well before most people are ever exposed.

Why it's given at this age

Why Grade 7 / early adolescence? The HPV vaccine works best when given before any exposure to the virus. Since HPV spreads through intimate contact, vaccinating in early adolescence — well before most people become sexually active — provides the strongest protection. It's not about expecting any particular behaviour; it's about building protection well in advance, the way you'd put on a seatbelt before driving rather than during a crash.

Why two doses? When the series is started between ages 9 and 14, the immune system responds especially well, and two doses (at least 6 months apart) provide strong protection. People who start the series at 15 or older, or who have certain immune conditions, may need three doses. A healthcare provider or public health unit can confirm the right number for an individual.

What if a dose is late? If the second dose is delayed, the series does not need to restart — the next dose can be given when possible. If the two doses end up given less than 6 months apart, a third dose may be recommended. See the Catch-Up & Missing Records page, or ask your public health unit.

Can it be given with other vaccines? Yes. In Grade 7, HPV is offered alongside the meningococcal ACYW and hepatitis B vaccines through the school program. These may be given at the same visit, at different injection sites.

A note on dose recommendations: In July 2024, Canada's National Advisory Committee on Immunization (NACI) updated its guidance to recommend a single dose of HPV vaccine for most people aged 9 to 20. Ontario continues to offer and publicly fund a two-dose schedule for students in Grades 7 to 12, with a third dose funded for anyone who needs it. Recommendations in this area are evolving — your local public health unit can confirm the current Ontario approach.

School and reporting status

Important: HPV is offered at school, but it is not required for school attendance. The HPV vaccine is provided free through Ontario's Grade 7 school-based immunization program, but it is not listed as a required vaccine under the Immunization of School Pupils Act (ISPA). This means HPV is not an ISPA-designated disease for routine school attendance — unlike diphtheria, tetanus, polio, measles, mumps, rubella, meningococcal disease, pertussis, and varicella (for children born in 2010 or later). Missing the HPV vaccine does not usually trigger the same ISPA suspension process as missing a required vaccine, though families should confirm current requirements with their local public health unit.

This distinction is a common source of confusion, because the HPV vaccine is offered at school alongside the meningococcal ACYW vaccine — and meningococcal disease is ISPA-required. It's easy to assume everything offered in the school clinic carries the same requirement, but they don't. HPV (and hepatitis B) are publicly funded, school-based, and recommended, but participation is a choice rather than a school-attendance requirement.

What "school-based" means here: Public health nurses typically visit schools to offer these vaccines, which makes them convenient and accessible. Parents and caregivers are asked to provide consent. If your child misses the school clinic, the vaccine remains free through your local public health unit (through Grade 12), and sometimes through other providers.

Reporting: When the vaccine is given through a school-based clinic run by public health, the public health unit usually records it directly. If your child receives HPV vaccine elsewhere, you may need to report it to your local public health unit yourself.

What's in this vaccine

The HPV vaccine used in Ontario's program is Gardasil®9 (Merck). The information below is based on its Health Canada product monograph. Gardasil 9 is not a live vaccine and does not contain any virus — it uses lab-made proteins that mimic the outer shell of the virus.

Ingredient / Component Category Why it's there Plain-English explanation
HPV L1 proteins (types 6, 11, 16, 18, 31, 33, 45, 52, 58) Active ingredients These are the parts that train the immune system to recognize HPV. These are purified proteins that self-assemble into "virus-like particles" — empty shells that look like the outside of HPV to the immune system, but contain no genetic material and cannot cause infection.
Amorphous aluminum hydroxyphosphate sulfate (AAHS) Adjuvant Helps the immune system respond more strongly and produce longer-lasting protection. An aluminum-based adjuvant. Aluminum salts have been used safely in vaccines for decades, in small amounts. This is discussed further in the "What the evidence shows" section.
Yeast protein (trace amounts) Manufacturing process residual / potential allergen The HPV proteins are grown using baker's yeast (Saccharomyces cerevisiae), so trace amounts of yeast protein may remain. This is relevant for anyone with a known severe yeast allergy — discuss it with a healthcare provider if it applies to your child.
Polysorbate 80 Stabilizer / potential allergen Helps keep the vaccine's ingredients evenly mixed and stable. A common ingredient in many foods, cosmetics, and medications. Listed as a potential allergen in the product monograph, though severe reactions to it are rare.
L-histidine Buffer Helps keep the vaccine at a stable acidity (pH). An amino acid (a building block of protein) that the body uses normally and that helps keep the vaccine stable.
Sodium borate Buffer Helps maintain the vaccine's stability and acidity. Used in very small amounts as a buffering agent to keep the product stable.
Sodium chloride Tonicity agent Helps match the vaccine's salt concentration to that of the body. Ordinary salt, used so the injection is gentler on the body's tissues.
Water for injection Base The liquid base of the vaccine. Sterile water that makes up most of the injection's volume.

Side effects and safety

Expected / common side effects

  • Soreness, redness, or swelling where the needle was given
  • Headache
  • Mild fever
  • Nausea or dizziness
  • Tiredness

Timing and duration: These reactions usually appear within a day or so and typically resolve within 1–2 days.

Fainting: Fainting can happen after any vaccine in adolescents, and is more about the experience of being vaccinated than the vaccine itself. Because of this, the person giving the vaccine may ask your child to sit or stay nearby for about 15 minutes afterward. Let the clinic know if your child has fainted with needles before.

Home care: A cool compress can help with injection-site soreness. Acetaminophen or ibuprofen may be used as directed for discomfort or fever. People under 19 should not be given ASA (Aspirin) or salicylate-containing products.

Mild side effects can happen as the immune system responds. Many people have no side effects at all, and that does not mean the vaccine didn't work.

Rare but important

  • Severe allergic reaction (anaphylaxis) — reported rarely after vaccination in general; exact frequency varies by source.
  • Injury from fainting — the main rare-but-important concern is a fall if someone faints, which is why a brief observation period is recommended.

What clinics do to reduce risk: Clinics ask about allergy history before vaccination, are equipped with epinephrine and trained staff, and have your child sit during and after the injection to reduce the chance of injury from fainting.

Observation period: Staying seated and nearby for about 15 minutes after the vaccine is recommended, which addresses both rare severe allergic reactions and the more common possibility of fainting.

A note on safety monitoring: HPV vaccines have been used for over 15 years and have been studied extensively in millions of people. They continue to be monitored for safety.

Get urgent help now if your child has:

  • Trouble breathing
  • Swelling of the lips, tongue, throat, or face
  • Widespread hives together with breathing difficulty
  • Severe weakness, limpness, or unresponsiveness
  • A seizure
  • A fall or injury from fainting that seems serious
  • A high or persistent fever
  • Any symptom that feels serious or is rapidly getting worse

If any of these occur, go to the nearest emergency department or call 911. Otherwise, contact a healthcare provider and let them know what happened — this information also helps with vaccine safety monitoring.

Who should pause or speak with a healthcare provider first

Speak with a healthcare provider before this vaccine if:

  • Your child has had a serious allergic reaction to a previous dose of HPV vaccine, or to any of its components (including yeast or polysorbate 80)
  • Your child is pregnant — HPV vaccine is not routinely given during pregnancy (it's not known to be harmful, but it's generally deferred until after)
  • Your child has a moderate or severe acute illness (it's generally fine to wait until they feel better)
  • Your child has fainted with needles or vaccines before — not a reason to avoid it, but worth telling the clinic so they can take extra care

These usually do NOT require delaying this vaccine:

  • A mild cold or other minor illness without fever
  • A stable, ongoing chronic health condition
  • Currently taking antibiotics for an unrelated condition
  • Having a weakened immune system — HPV is not a live vaccine, so it can generally be given (and three doses may be recommended)

Questions parents often ask

No. The HPV vaccine is offered free through the Grade 7 school program and is recommended, but it is not an ISPA-designated disease for routine school attendance. Missing it does not usually trigger the same suspension process as a required vaccine, though it's best to confirm current requirements with your local public health unit. See the School Requirements hub for the full list of what is required.
That's exactly the point — the vaccine works best when given before any possible exposure to HPV. Giving it in early adolescence means the protection is fully in place well ahead of time. The immune system also responds especially strongly at this age, which is why only two doses are needed when started before age 15.
Yes. Ontario's program offers HPV vaccine to all students in Grade 7, regardless of gender. HPV can cause cancers and other diseases in people of any sex, and vaccinating everyone also reduces the spread of the virus in the community.
When started between ages 9 and 14, Ontario funds two doses given at least 6 months apart. A third dose is publicly funded for anyone who needs it (for example, if the doses were given too close together, or for those with certain immune conditions). Your public health unit can confirm the right schedule.
The vaccine remains free through your local public health unit, and catch-up is publicly funded through Grade 12. Contact your public health unit to arrange a dose. See the Catch-Up & Missing Records page for more.
No. There is no evidence that the HPV vaccine harms fertility. This is addressed in more detail in the "What the evidence shows" section below. In fact, by preventing cervical cancer and the treatments it can require, HPV vaccination helps protect future fertility.
Yes. The vaccine protects against most, but not all, cancer-causing HPV types, so routine cervical screening in adulthood is still recommended. The vaccine and screening work together to provide the best protection.
Mild soreness, headache, or tiredness for a day or two are common. Because fainting can happen in adolescents, make sure your child is seated for a bit afterward. Review the "Get urgent help now" list above — if any of those signs occur, seek urgent care.

What we know about fertility and HPV vaccination

Fact There is no evidence that the HPV vaccine harms fertility in any way.
Concern Some online rumours have claimed the HPV vaccine could affect a young person's future ability to have children. This worry has circulated widely on social media.
Evidence Large studies following vaccinated and unvaccinated people over time have found no link between HPV vaccination and infertility or early menopause. The rumour is not supported by the evidence. In contrast, HPV is a known cause of cervical cancer, and the treatments required for cervical cancer or precancer can themselves affect fertility — so preventing HPV infection can actually help protect future fertility.
Takeaway HPV vaccination protects against several cancers without any demonstrated effect on fertility. If you've seen claims to the contrary, a healthcare provider can talk them through with you.
Fact The aluminum adjuvant in the HPV vaccine is present in a very small amount and has a long track record of safe use in vaccines.
Concern Some parents are concerned about aluminum in vaccines, having heard it described as a "toxin."
Evidence Aluminum is one of the most common elements on earth, and we're all exposed to small amounts every day through food and water. Aluminum-based adjuvants have been used in vaccines for decades to strengthen the immune response. The amount in a vaccine dose is small, and the body processes and clears it over time. Major safety reviews have not found that the aluminum in vaccines causes harm at these amounts.
Takeaway The aluminum adjuvant is there to make the vaccine work better, in an amount supported by a long safety record. The "Safety & Ingredients" hub explains adjuvants in more depth.

What to do next

Where to get it

Offered free through Grade 7 school clinics run by your local public health unit. Also available free through the public health unit (through Grade 12).

What to bring / do

Watch for the consent form sent home through school, and return it on time. Note any allergies or a history of fainting with needles.

If you missed the school clinic

Contact your local public health unit to arrange a free dose. Catch-up is funded through Grade 12.

If records are missing

Your public health unit usually records school-clinic doses directly. Contact them to confirm what's on file.

If vaccinated outside Ontario

Bring any records to a healthcare provider or public health unit so the series can be reviewed and continued if needed.

Contact public health

For consent questions, scheduling, or to report a dose given elsewhere, see the Resources page for your local public health unit.

Where this information comes from

This page is based on:

Last reviewed: June 2026  ·  Next review due: December 2026
Schedules, products, and eligibility can change. Always confirm current details with your healthcare provider, your local public health unit, or official Ontario sources.

Please note: This is an independent website. It is not affiliated with, endorsed by, or operated by the Government of Ontario, the Ministry of Health, or any public health unit. The information here is for general education only and is not medical advice — always consult a licensed healthcare provider about your or your child's immunizations.